Wicka '90 Uses Entrepreneurial Skills to Develop New Drug
December 27, 2011
The Wall Street Journal recently featured Tom Wicka, who purchased a developing drug and is using his entrepreneurial skills to control operations. Wicka hopes to launch a clinical trial next year with the goal of developing a drug that will alleviate Duchenne muscular dystrophy. Wicka's son, Nash, suffers from the genetic neuromuscular disorder which primarily strikes boys and currently has no cure.